Navigation Links
Unique soybean lines hold promise for producing allergy-free soybeans

Researchers have isolated two Chinese soybean lines that grow without the primary protein linked to soy allergies in children and adults. The two lines already are adapted to Illinois-like conditions and will be given away to breeders seeking to produce new varieties of allergy-free soybeans without genetic engineering.

Crop scientists at the University of Illinois at Urbana-Champaign and the USDA-Agricultural Research Service's Donald Danforth Plant Science Center in St. Louis screened more than 16,000 soybean lines kept in the USDA's National Soybean Germplasm Collection. The findings will appear later this year in the journal Crop Science.

The two soybean lines (PI 567476 and PI 603570A) contain virtually identical genetic mutations that do not contain the leading allergy-causing P34 protein, which consists of 379 amino acids, said Theodore Hymowitz, emeritus professor of plant genetics in the crop sciences department at the U. of I.

"We are releasing this information with no patents so that companies and breeders involved with soybeans can incorporate these two lines as quickly as possible," Hymowitz said. Companies in Japan, Canada and across the United States have been following the research effort, he added.

The research, which was funded primarily by the Illinois-Missouri Biotechnology Alliance, went through two stages.

First, using a specially developed immunochemistry approach, Hymowitz's post-doctoral assistant Leina M. Joseph examined 100 lines of soybeans per day for nine months from the UI-based collection. Seeds were crushed, treated and placed on a membrane for screening. A second screening using stronger antibodies and protein gels was done to confirm the absence of P34 in the two domestic lines, Joseph said.

After the two lines were isolated, seeds were sent to the Danforth Center for additional molecular analysis to determine why P34 was absent. Six identical genetic mutations were found in each, indi
'"/>

Source:University of Illinois at Urbana-Champaign


Page: 1 2

Related biology news :

1. Breast Cancer May Be Uniquely Sensitive To Inhibitors Of PI3K Pathway
2. Unique library of plant genes germinates, takes root at UNC
3. Invitrogen Launches i-Path -- A Unique Systems Biology Platform at BIO 2005
4. Uniquely human component of language found in gregarious birds
5. Unique equine cataract surgery offered on routine basis
6. Unique dual target specificity of kinase inhibitor key for success against cancer
7. Unique gene regulation gives chilly bugs survival advantage at bottom of the world
8. Unique tomatoes tops in disease-fighting antioxidants
9. Techniques available to detect soil that inhibits destructive soybean pest
10. Current human embryonic stem cell lines contaminated UCSD/Salk team finds
11. HIV-1 spread through six transmission lines in the UK

Post Your Comments:
(Date:11/9/2009)...peful news is that pediatric survival rates have s...eatments that enable survival often cause infertil...ched puberty currently have an opportunity to pres...atment, they may have their semen frozen and prese... produce sperm, although their testicular tissue c...
(Date:11/9/2009)...Energy (DOE) has announced plans to fund research ...chool of Engineering on technologies that would he...ture and permanent safe storage, or sequestration,...oration with Southern Company, the parent company ...e 2009 American Recovery and Reinvestment Act, the...
(Date:11/9/2009)...is publishing a special issue "Beyond the Origin: ...Darwin,s On the Origin of Species which was publis...nd author of the lead article is Dr. Ulrich Kutsch...y biology at the University of Kassel in Germany. ...ree of charge until 30 December 2009 on Springer,s...
Breaking Biology News(10 mins):For young boys with cancer, testicular tissue banking may be option to preserve fertility 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 3UAB, partners seek safe carbon dioxide storage for 'greener' power generation 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 3ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2009 Financial Results 5193 1Growing greener greens 10244 1Growing greener greens 10244 2Growing greener greens 10244 3Drug May Help Colitis Patients Avoid Surgery 58775 1
...es of shepherds and travellers encountering lions,...tales about attacks on flocks and people by these ...most of their former range, but for livestock owne... with lions is a daily reality. Although loss of h...ost the herders close to 1000 US$ per family each ...
...was launched today by the Chinese National Space A...e Xichang Satellite Launch Centre, Sichuan, atop a...first step in the Chinese ambition to land robotic... four mission goals to accomplish. The first is to...orms and outline maps of major lunar geological st...
... Germany-October 24, 2007-Harvard University,s Off... announced an agreement to jointly establish the B...at Harvard,s School of Engineering and Applied Sci...ng strong ties with departments and schools throug...ative, integrated partnership among Harvard and BA...
Other Biology News:Living with lions 2Chang'e-1 -- new mission to Moon lifts off 2BASF and Harvard University announce extensive research collaboration 2
(Date:11/6/2009).../PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (...y") today announced updated results from a Phase I...h sarcomas metastatic to the lung in a poster pres...logy Society Meeting held in Miami Beach, Florida,..., entitled "A Phase II Study of Intravenous REOLYS...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Personal...t to take place on February 22-24, 2010 in Philade...rence we will highlight key issues in forming part...ir experiences. , Minneap...r Arrowhead’s 2010 Personalized Medicine Pa...
(Date:11/5/2009)...., Nov. 5 GenVec, Inc. (...lts for the third quarter ended September 30, 2009...4 per share) for the three months ended September ...0.08 per share) in the comparable quarter of 2008....Vec,s net loss was $14.1 million ($0.15 per share)...
(Date:11/5/2009)..., Nov. 5 DSM Pharmaceutical Produc...g alliance with Galenix, Saint Jean D,Illac, Franc...e manufacturing partner for Galenix commercial pro...l collaborate on business development opportunitie... based on the strength of Galenix in drug product ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...ION CITY, Calif., June 2 Santen,Pharmaceutical Co...he two,companies have entered into a research and ...r the Japanese and Asian development and,commercia...diseases and,conditions including wet age related ...r edema (DME). Sirolimus, originally known as rapa...
...tic mutations that can affect patient response to ...EASANTON, Calif., June 2 Roche and DxS Ltd. have,... DxS TheraScreen K-RAS,Mutation Test and TheraScre...when considered with other clinically relevant fac...nts likely to benefit from a specific,cancer thera...
... the 44th Annual Meeting of,the American Society o...nted investigating the potential utility of Zevali...replacement for external beam radiations or,supple... non-Hodgkin,s,lymphoma (NHL). Cell Therapeutics, ...n the United States., "These two studies add to t...
Other Biology Technology:Santen and MacuSight Announce Collaboration and License Agreement for Sirolimus in Ocular Diseases and Conditions 2Santen and MacuSight Announce Collaboration and License Agreement for Sirolimus in Ocular Diseases and Conditions 3Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests 2Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests 3Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin's Lymphoma 2Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin's Lymphoma 3Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin's Lymphoma 4
Silencer siRNA Starter Kit from Ambion
...successful cell culture or fermentation is the abi...ocess, and make rapid adjustments in response to c...ry Analyzers provide immediate analysis of key nut... fermentation media. BioProfile analyzers are full...
...s Routine Testing Laboratory (RTL) can provide you...,,Microbial method development and validation...ditions of your GMP manufacturing environment ,A...,We offer a full spectrum of microbiological se...
...s a 20 amino acid synthetic peptide whose sequence...e sequence of this peptide is (amino to carboxy te... - V - P - N - E - V - L - G - P - E133 (C) (The C...njugation and is not a part of the native rat SAP9...
Biology Products: